Asunaprevir (a soo na pre veer)
Consumer Medicine Information
Warnings and Precautions
While you are are taking SUNVEPRA, your doctor will frequently monitor you for signs
of how well your liver is working. This will be done with regular blood tests.
If the results of these tests show a decline in how well your liver is working, a
decision will be made to stop your treatment with SUNVEPRA.
What is in this leaflet
Read this leaflet carefully before taking SUNVEPRA. This leaflet answers some common
questions about SUNVEPRA.
It does not contain all the available information.
It does not take the place of talking to your doctor or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the risks of you taking
SUNVEPRA against the benefits they expect it will have for you.
If you have any concerns about taking this medicine, ask your doctor or pharmacist.
Keep this leaflet with the medicine. You may need to read it again.
What SUNVEPRA is used for
SUNVEPRA is a trade name (manufacturer's name) for the medicine, asunaprevir. SUNVEPRA
is a direct acting antiviral agent (DAA) against the hepatitis C virus (HCV). SUNVEPRA
is an inhibitor of the HCV protein 3/4A (NS3/4A), a protease that is required to form
new HCV particles.
You should not take Sunvepra alone to treat chronic (lasting a long time) hepatitis
C infection in adults. SUNVEPRA should only be used together with another antiviral
medicine, daclatasvir (DAKLINZA), or together with DAKLINZA, peginterferon alfa, and
How SUNVEPRA Works
SUNVEPRA (in combination with other medicines) works by stopping the HCV from multiplying
and infecting liver cells. After you stop taking SUNVEPRA, your doctor will monitor
your blood for HCV. If HCV is still not detected in your blood at least 12 weeks after
stopping treatment, you have what is called a sustained virologic response (SVR),
also referred to as virologic cure.
It is not known if SUNVEPRA is safe and effective in children under 18 years of age.
Ask your doctor if you have any questions about why SUNVEPRA has been prescribed for
SUNVEPRA is not addictive. This medicine is available only with a doctor's prescription.
Before you take SUNVEPRA
It is important that you check the information below before you take SUNVEPRA.
When you must not take SUNVEPRA
SUNVEPRA is sometimes used with peginterferon alfa and ribavirin. Peginterferon alfa
and ribavirin may cause birth defects or death of your unborn baby. If you are pregnant
or planning to become pregnant, or your sexual partner is pregnant or plans to become
pregnant, do not take these medicines. You or your sexual partner should not become
pregnant while taking peginterferon alfa and ribavirin, and for 6 months after treatment
Two effective forms of birth control must be used, one by each partner, male and female,
during treatment and for the 6 months after treatment with peginterferon alfa and
ribavirin. Talk with your doctor about forms of birth control that may be used during
Females must have a negative pregnancy test before starting treatment with peginterferon
alfa and ribavirin, every month while being treated, and every month for 6 months
after your treatment ends.
If you or your female sexual partner becomes pregnant while taking, or within 6 months
after you stop taking, peginterferon alfa and ribavirin, tell your doctor right away.
Tell your doctor if you have or have had:
have a current or previous infection with the hepatitis B virus.
liver problems other than hepatitis C. Your doctor may tell you not to take SUNVEPRA
if you have certain liver problems.
Do not take SUNVEPRA if you have an allergy to it or to any other ingredients in the
formulation listed at the end of this leaflet.
Do not take SUNVEPRA if you are currently taking any of these medicines:
dexamethasone (when administered by injection or taken by mouth)
St. John's wort (Hypericum perforatum) or a product that contains St John's wort
If you are not sure if any of these medicines are in the products you are taking,
talk to your doctor or pharmacist.
Do not use SUNVEPRA after the expiry date printed on the back of the pack. If this
medicine is taken after the expiry date has passed, it may not work as well.
Do not take SUNVEPRA if the packaging is torn or shows signs of tampering.
Before you start to take SUNVEPRA
Tell your doctor if you:
had a liver transplant
have kidney problems
have any other medical condition
SUNVEPRA, when used with DAKLINZA, should not be used during pregnancy.
Tell your doctor if you are pregnant or intend to become pregnant.
It is not known if SUNVEPRA will harm your unborn baby.
If you can become pregnant and use oral contraception, use a "high-dose" contraceptive
that includes at least 30 mcg of ethinyl estradiol combined with norethindrone acetate/norethindrone.
A lower dose contraceptive may not work with SUNVEPRA.
If you are also taking ribavirin, you must follow the contraception instructions under
"When you must not take SUNVEPRA" above.
Tell your doctor or pharmacist if you are breast-feeding or plan to breast-feed.
It is recommended that you do not breast-feed while taking SUNVEPRA. It is not known
if SUNVEPRA passes into breast milk.
If you have not told your doctor about any of the above, tell them before you use
As SUNVEPRA should only be used together with another antiviral medicine such as DAKLINZA,
or together with DAKLINZA, peginterferon alfa, and ribavirin, please read the Consumer
Medicine Information for the other products prescribed by your doctor before starting
Taking other medicines
Be sure to inform your doctor of all medications you are taking including prescribed
drugs, over the counter products, natural therapies, vitamin supplements and recreational
SUNVEPRA and other medicines may affect each other. This can cause you to have too
much or not enough SUNVEPRA or other medicines in your body, which may affect the
way SUNVEPRA or your other medicines work, or may cause side effects.
Medicines for other conditions:
Do not take SUNVEPRA if you are currently taking any of the medicines listed under
"When you must not take SUNVEPRA" above.
Tell your doctor if you are taking or starting to take medicines that contain:
amitriptyline, imipramine, or nortriptyline
dextromethorphan (a cough suppressant that is an ingredient in many over-the counter
midazolam rosuvastatin, atorvastatin, fluvastatin, simvastatin, pitavastatin, or pravastatin
warfarin and other similar medicines called vitamin K antagonists used to thin the
Your doctor will be able to advise you about the most appropriate medications to treat
your condition. It is important that you tell your doctor or pharmacist about the
medicines you are taking, even if they are not listed in this leaflet.
They will be able to provide you with more information than is contained within this
leaflet on the medicines you need to be careful with, or should avoid while taking
How to take SUNVEPRA
SUNVEPRA should be given only when prescribed by your doctor. Follow all directions
given to you by your doctor or pharmacist carefully. They may differ from the information
contained in this leaflet.
How much to take
Take SUNVEPRA exactly as your doctor tells you to take it. Do not change your dose
unless your doctor tells you to.
Do not stop taking SUNVEPRA without first talking with your doctor. If you think there
is a reason to stop taking SUNVEPRA, talk with your doctor before doing so.
How to take it
Swallow the capsule whole with a drink such as a glass of water.
When to take SUNVEPRA
Take SUNVEPRA two times each day with or without food.
How long to take it
Continue taking SUNVEPRA for as long as your doctor tells you to.
Do not stop taking SUNVEPRA unless your doctor tells you to - even if you feel better.
If you forget to take it
If you miss a dose of SUNVEPRA and less than 8 hours have passed since you were to
take the missed dose, take the missed dose as soon as possible. Take the next dose
at your regular time.
If you miss a dose of SUNVEPRA and more than 8 hours have passed since you were to
take the missed dose, skip the missed dose. Take the next dose at your regular time.
Do not take two doses of SUNVEPRA at the same time to make up for the missed dose.
If you take too much (overdose)
Immediately call your doctor or the Poisons Information Centre on 131126 in Australia,
or go to the Accident and Emergency Centre at your nearest hospital if you or anyone
else takes too much Sunvepra.
Do this even if there are no signs of discomfort or poisoning.
While you are using SUNVEPRA
Things you must do
If you become pregnant while taking SUNVEPRA, tell your doctor immediately.
If you are about to start taking any new medicines, tell your doctor and pharmacist
that you are taking SUNVEPRA. SUNVEPRA or the other medicine may interfere each other.
Some people taking SUNVEPRA have had abnormal results on tests that show how well
the liver is working, occasionally accompanied by serious liver problems. Your doctor
will monitor these tests while you take SUNVEPRA. If the results show a decline in
how well your liver is working, your doctor may instruct you to stop taking SUNVEPRA.
Things you must not do
Do not give SUNVEPRA to anyone else, even if they have the same condition as you.
Do not use SUNVEPRA to treat any other complaints unless your doctor tells you to.
Do not stop taking SUNVEPRA without checking with your doctor.
Things to be careful of
Be careful driving or operating machinery until you know how SUNVEPRA affects you.
Make sure that you visit your doctor regularly throughout your entire course of treatment
Tell your doctor or pharmacist as soon as possible if you do not feel well while you
are taking SUNVEPRA. All medicines can have side effects. Sometimes they are serious,
most of the time they are not. You may need medical treatment if you get some of the
Ask your doctor or pharmacist to answer any questions you may have.
The most common side effects when SUNVEPRA is taken in combination with DAKLINZA include:
nasal congestion (blocked nose)
The most common side effects when SUNVEPRA is taken in combination with DAKLINZA,
peginterferon alfa, and ribavirin include:
If any of the following happen, tell your doctor immediately, or go to the Accident
and Emergency Centre at your nearest hospital:
allergic reaction - swelling of the face, lips, or throat which makes breathing difficult
If you have these side effects, you may have had a serious reaction to SUNVEPRA. You
may need urgent medical attention or hospitalisation.
This is not a complete list of side effects, other side effects not listed above may
also occur in some patients.
Tell your doctor if you notice anything that is making you feel unwell.
Do not be alarmed by this list of possible side effects. You may not experience any
of them or only some of them.
After using SUNVEPRA
Store SUNVEPRA Capsules in a cool dry place where the temperature stays below 25°C.
Keep your capsules in the original container until it is time to take them.
Do not store SUNVEPRA or any other medicine in the bathroom or near the kitchen sink.
Do not leave it in the car. Heat and dampness can destroy some medicines.
Keep SUNVEPRA capsules where children cannot reach them. A locked cupboard at least
one-and-a-half metres above the ground is a good place to store medicines.
If your doctor tells you to stop taking SUNVEPRA capsules, or the capsules have passed
their expiry date, ask your pharmacist what to do with any that are left over.
What it looks like
SUNVEPRA 100 mg capsules are available as oval, opaque white to pale-yellow, soft-gelatin
capsule containing 100 mg asunaprevir
Capsules are imprinted with "BMS" in black on one line and "711" in black on a second
line below "BMS."
Available in packs of 14 and 56 capsules.
Each capsule contains:
SUNVEPRA 100 mg capsules - 100 mg of asunaprevir per capsule
medium-chain triglycerides, caprylic/capric glycerides, polysorbate 80, and butylated
The capsule shell contains gelatin, partially dehydrated liquid sorbitol, glycerol,
titanium dioxide and OPACODE Black (printing ink).
SUNVEPRA 100 mg - AUST R 222744
Bristol-Myers Squibb Australia Pty Ltd,
4 Nexus Court, Mulgrave,
Victoria 3170, Australia
This information in no way replaces the advice of your doctor or pharmacist.
Date of Preparation: April 2019
V3 9 April 2019